CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

LUPIN LTD.

NSE : LUPINBSE : 500257ISIN CODE : INE326A01037Industry : Pharmaceuticals & DrugsHouse : Lupin
BSE2356.8511.35 (+0.48 %)
PREV CLOSE () 2345.50
OPEN PRICE () 2340.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12551
TODAY'S LOW / HIGH ()2305.60 2362.05
52 WK LOW / HIGH ()1774 2376
NSE2357.3012.7 (+0.54 %)
PREV CLOSE() 2344.60
OPEN PRICE () 2337.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2357.30 (2)
VOLUME 870863
TODAY'S LOW / HIGH() 2306.00 2361.40
52 WK LOW / HIGH ()1795.2 2377.6
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1983

Management Info :

Manju D Gupta - Chairman Nilesh Gupta - Managing Director

Registered Office :

Address : Kalpataru Inspire, 3rd Floor,Off. Western Express Highway,Santacruz (East),
Mumbai,
Maharashtra-400055

Phone : 022 66402323

Email : info@lupin.com

Website : www.lupin.com

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
09Mar USFDA concludes inspection with two ob
US Food and Drug Administration (USFDA) has concluded an inspection at L..
09Mar Lupin declines after USFDA concludes i
Lupin is currently trading at Rs. 2288.50, down by 55.95 points or 2.39%..
07Mar Lupin informs about press release
Lupin has informed about Newspaper Publication regarding Special Window..
02Mar Lupin inches up on the BSE
Lupin is currently trading at Rs. 2302.25, up by 0.90 points or 0.04% fr..
27Feb Lupin receives EIR from USFDA for Goa
Lupin has received the Establishment Inspection Report (EIR) from the Un..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit7174.5000000000139729.6
Gross Profit 8679.40000000001 48371.2
Operating Profit 17164.856465.3
Net Sales 45011.9169675
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
RPG Life Sciences (BSE)
 1970.30 (4.30%)
M.Cap ( in Cr)
3258.68
Ajanta Pharma (BSE)
 3122.15 (2.52%)
M.Cap ( in Cr)
39006.78
Venus Remedies (BSE)
 927.50 (7.46%)
M.Cap ( in Cr)
1239.79
Ipca Laboratories (BSE)
 1559.55 (1.79%)
M.Cap ( in Cr)
39566.44
Jubilant Pharmova (BSE)
 830.55 (2.68%)
M.Cap ( in Cr)
13229.09
Shareholding Pattern
PROMOTERS 46.89%
MUTUAL FUNDS/UTI 18.01%
NON-INSTITUTION 6.03%
FI/BANKS/INSURANCE 5.59%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX76034.42-829.29 (-1.08%)
NIFTY23639.15-227.70 (-0.95%)
Dow Jones 46677.85-739.42 (-1.56%)
Nasdaq 22311.98-404.15 (-1.78%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI